[Flow fluorimetry in differential diagnosis of diffuse large B-cell lymphoma]

Terapevticheskii Arkhiv
|September 2, 2006
PubMed

Insights

Flow cytometry effectively identifies B-cell clonality and assesses tumor cell proliferation in diffuse large B-cell lymphoma (DLBCL). This method aids in precise diagnosis and understanding of DLBCL tumor biology.

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Context:

  • Diffuse large B-cell lymphoma (DLBCL) is an aggressive non-Hodgkin lymphoma.
  • Accurate immunophenotyping is crucial for DLBCL diagnosis and subclassification.
  • Flow cytometry offers a rapid and sensitive method for cellular analysis.

Purpose:

  • To analyze the immunophenotype of diffuse large B-cell lymphoma (DLBCL) using flow cytometry.
  • To evaluate the utility of flow cytometry in assessing B-cell clonality and proliferative potential in DLBCL.

Summary:

  • Flow cytometry analysis of DLBCL revealed phenotypes often resembling marginal zone lymphoma cells.
  • Studying cells with maximal light diffusion provided more precise clonality and proliferative potential assessment.
  • The proliferative index in 33 DLBCL cases ranged from 10-60%.

Impact:

  • Flow cytometry enables reliable identification of B-cell clonality in most DLBCL cases.
  • This technique allows for a more precise evaluation of the tumor's proliferative capacity.
  • Enhanced diagnostic capabilities for DLBCL management and research.
Abstract